Eosbioinnovation
1 known investors
Eos incubates, launches, and builds early-stage companies developing therapies and technologies in regenerative medicine, spanning small molecules, cell and gene therapies, engineered biomaterials, and enabling technologies. It works with academic labs and research institutions, particularly the Harvard Stem Cell Institute and Harvard-affiliated research centers, to identify and fund innovations aimed at repairing or regenerating organs, tissues, cells, and genes.
BiotechHealthtechLongevity